Found: 29
Select item for more details and to access through your institution.
Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 6, p. 631, doi. 10.1002/ajh.23167
- By:
- Publication type:
- Article
Validation of a multivariable prediction model for post‐engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
- Published in:
- Mycoses, 2019, v. 62, n. 5, p. 418, doi. 10.1111/myc.12891
- By:
- Publication type:
- Article
Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2012, v. 4, n. 1, p. 1, doi. 10.4084/MJHID.2012.011
- By:
- Publication type:
- Article
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417
- By:
- Publication type:
- Article
Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.66190
- By:
- Publication type:
- Article
Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
- Published in:
- Revista Española de Quimioterapia, 2013, v. 26, n. 1, p. 64
- By:
- Publication type:
- Article
Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia.
- Published in:
- Transfusion, 2011, v. 51, n. 7, p. 1546, doi. 10.1111/j.1537-2995.2010.03042.x
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
Kinetic of regulatory CD25<sup>high</sup> and activated CD134<sup>+</sup> (OX40) T lymphocytes during acute and chronic graft- versus-host disease after allogeneic bone marrow transplantation.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 5, p. 697, doi. 10.1111/j.1365-2141.2004.05108.x
- By:
- Publication type:
- Article
Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 3, p. 686, doi. 10.1111/j.1365-2141.2002.3311a.x
- By:
- Publication type:
- Article
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054458
- By:
- Publication type:
- Article
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 12, p. 2003, doi. 10.1002/cncr.33403
- By:
- Publication type:
- Article
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1239, doi. 10.1111/bjh.18815
- By:
- Publication type:
- Article
A prognostic model for survival after salvage treatment with FLAG-Ida +/− gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 700, doi. 10.1111/bjh.14107
- By:
- Publication type:
- Article
Tumor necrosis factor-α-secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2010, v. 25, n. 12, p. 1869, doi. 10.1111/j.1440-1746.2010.06377.x
- By:
- Publication type:
- Article
Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1425, doi. 10.3390/cancers15051425
- By:
- Publication type:
- Article
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 438, doi. 10.3390/cancers15020438
- By:
- Publication type:
- Article
Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5799, doi. 10.3390/cancers14235799
- By:
- Publication type:
- Article
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3 -ITD Mutation-Positive Acute Myeloid Leukemia.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2817, doi. 10.3390/cancers14112817
- By:
- Publication type:
- Article
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092342
- By:
- Publication type:
- Article
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2458, doi. 10.3390/cancers13102458
- By:
- Publication type:
- Article
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2171, doi. 10.3390/cancers12082171
- By:
- Publication type:
- Article
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
- Published in:
- Disease Markers, 2022, p. 1, doi. 10.1155/2022/3132941
- By:
- Publication type:
- Article
Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 12, p. 1667, doi. 10.3390/jpm13121667
- By:
- Publication type:
- Article
Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae.
- Published in:
- 2016
- By:
- Publication type:
- journal article
People’s Ability to Detect Objects Using Click-Based Echolocation: A Direct Comparison between Mouth-Clicks and Clicks Made by a Loudspeaker.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0154868
- By:
- Publication type:
- Article